Despite low cost and wide availability, Ki67 assessment is not yet fully established in routine breast cancer diagnostics, due to methodological problems in determination and unclear clinical cutoffs (Hicks and Tubbs 2005; Curigliano et al. 2017). The gene discussed is MKI67; the disease is breast carcinoma.